AstraZeneca plc (LON: AZN) has recently received a number of price target changes and ratings updates: 4/1/2016 – AstraZeneca plc had its “outperform” rating reaffirmed by analysts at BNP Paribas. They now have a GBX 5,000 ($71.18) price target on the stock. 4/1/2016 – AstraZeneca plc had its “buy” rating reaffirmed by analysts at Deutsche […]
